MedTrace Logo

Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods

NCT06515821 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4100

Last updated 2025-09-10

No results posted yet for this study

Summary

The primary goal is to develop easy accessible diagnostic tools for high risk subjects for colon cancer in different European populations to improve early CRC detection. These CRC screening technologies would be low cost, breakthrough and of high sensitivity and specificity.

Conditions

Interventions

DIAGNOSTIC_TEST

ONCOSCREEN

Subjects samples will be tested with diagnostic tests.

Sponsors & Collaborators

  • University Medical Center Mainz

    collaborator OTHER

  • Firalis SA

    lead INDUSTRY

Principal Investigators

  • Markus MOELHER, MD, PhD · University Medical Center Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Bulgaria
  • France
  • Germany
  • Lithuania
  • Portugal
  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06515821 on ClinicalTrials.gov